LUMICKS
Netherlands · $93.0M raised
- Business Model
- B2B
- Website
- lumicks.com
- Total Funding
- $93.0M
- Last Round
- $93.0M Series DApr 2021
- Rounds
- 3
About
Next-generation life science tools company enabling immuno-oncology research and drug development through single-molecule and cell avidity technologies.
Summary
LUMICKS is a Biotech company based in Netherlands. It has raised $93.0M in total across 3 rounds, most recently a $93.0M Series D round in Apr 2021. Investors include Gilde Healthcare, European Investment Bank and Farallon Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...